etoricoxib, omeprazol, Alvedon (Filmdragerad tablett), Movicol (Pulver till oral lösning i dospåse), Targiniq (Depottablett), Eliquis (Filmdragerad tablett), OxyNorm (Kapsel, hård)
  • etoricoxib
  • omeprazol
  • Alvedon (Filmdragerad tablett)
  • Movicol (Pulver till oral lösning i dospåse)
  • Targiniq (Depottablett)
  • Eliquis (Filmdragerad tablett)
  • OxyNorm (Kapsel, hård)


Janusmed interaktioner


1 interaktion mellan valda läkemedel
Lägg till
Läkemedelsprodukt / substans
Alvedon (Filmdragerad tablett)
paracetamol (Enteral peroral)
Eliquis (Filmdragerad tablett)
apixaban (Enteral peroral)
etoricoxib (Enteral och parenteral)
Movicol (Pulver till oral lösning i dospåse)
makrogol (Enteral peroral)
natrium (Enteral peroral)
natriumvätekarbonat (Enteral peroral)
OxyNorm (Kapsel, hård)
oxikodon (Enteral peroral)
Targiniq (Depottablett)
naloxon (Enteral peroral)
oxikodon (Enteral peroral)
C0 C0
C0 C0

apixaban - etoricoxib

apixaban - etoricoxib

Klass : C0

  1. ELIQUIS (apixaban), Bistol-Meyers Squibb/Pfizer EEIG. SPC. 2011.
  2. , Alexander JH, Becker RC, Bhatt DL, Cools F, Crea F et al. Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial. Circulation. 2009;119:2877-85.
  3. Frost C, Shenker A, Gandhi MD, Pursley J, Barrett YC, Wang J et al. Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban. Br J Clin Pharmacol. 2014.
  4. Lee MT, Park KY, Kim MS, et al. Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding. Yonsei Med J. 2020 Sep;61(9):741-9.
  5. Dalgaard F, Mulder H, Wojdyla DM, et al. Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial. Circulation. 2020 Jan 7;141(1):10-2.
  6. Kent AP, Brueckmann M, Fraessdorf M, et al. Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2018 Jul 17;72(3):255-67.
  7. Kreutz R, Haas S, Holberg G, Lassen MR, Mantovani LG, Schmidt A et al. Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co-medication interactions. Br J Clin Pharmacol. 2016;81:724-34.
  8. Olsen AS, McGettigan P, Gerds TA, et al. Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study. Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):292-300.